Pollen News and Research

RSS

Microbes in your gut could be cause of allergies

Allergies making your life miserable? Tired of popping antihistamines like candy? Can't go anywhere without your inhaler? The real problem may not be your stuffed-up head. It could be the microbes in your gut.

1 Jun 2004

Antibiotics could be the cause of many allergies

27 May 2004

New Yorkers reminded to practice good asthma management

The New York City Department of Health and Mental Hygiene (DOHMH) today reminded New Yorkers with asthma - who may be at risk of increased symptoms during allergy season - to practice good asthma management, including identifying and avoiding asthma triggers and taking appropriate medications as directed by a health care provider.

5 May 2004

Parents who smoke at home much more likely to have children who suffer from asthma all year round

Children with asthma whose parents smoke at home are twice as likely to have asthma symptoms all year long than children of non-smokers, a new study shows.

4 May 2004

Australian research helps to better understand asthma, hayfever, eczema and associated allergies

May 4, 2004 is World Asthma Day. Asthma, hayfever, eczema and associated allergies are among the most common chronic diseases in the developed world. It has been estimated that up to 50% of people in western societies suffer from these conditions, and in Australia alone, health care costs for asthma alone exceed $700 million each year.

29 Apr 2004

Millions of poor and minority children in America's cities likely will suffer higher rates of asthma

Millions of poor and minority children in America's cities likely will suffer even higher rates of asthma as the result of a "powerful one-two punch" of higher levels of pollen and changes in the types of molds spurred by global warming, along with unhealthy urban air masses caused by the burning of fossil fuel by cars, trucks and buses, according to a warning issued today by Harvard researchers and the American Public Health Association (APHA).

29 Apr 2004

Forward step in treatment of Allergic Rhinitis

Rigel Pharmaceuticals, Inc. has announced the presentation of clinical data for R112, the company’s lead candidate for the treatment of allergic rhinitis, during a poster session at the annual meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI) in San Francisco, CA. The phase I/II single dose trial demonstrated that R112 was well tolerated and showed favorable biological effects.

22 Mar 2004